Commercial Data Strategy
Build a data strategy that supports your launch and scales with your pipeline.
A strong commercial data strategy connects the dots between your systems, teams, and insights. Whether you’re preparing for launch or rethinking how your data supports decision-making, Stratos helps biopharma companies design flexible, scalable architectures tailored to their goals. From assessing gaps to building roadmaps, we ensure your data is ready when it matters most.
Our Approach
Some describe how they can help get you there, we make you a map.
Built on real-world examples, industry best practices, and innovations, our Technical Roadmaps are customized to each client with the goal of organizing and prioritizing key mission-critical business systems that will help scale your business into the future. A Stratos Roadmap guides future decisions and strategic project budgeting, whether it’s the next year or the next half decade.
Commercial Data Strategy Expertise
Technology Evaluations
Data Quality & Governance
Analytics Roadmap
Data Architecture
Case Studies
Driving Pharma IT Efficiency Through a Center of Excellence
“The goal is to turn data into information and information into insight.” That quote by the former CEO of a multinational information technology company might sound simplistic, but businesses that lack quality data face myriad repercussions, from increased workloads...
Pharma Replaces Costly Sales Portal With User-Friendly Analytics Solution
We’ve all heard — and probably used – the saying: “If it ain’t broke, don’t fix it!” It’s true for a lot of things in life, from keeping a product style the same to holding off on updates to your house. Avocado and rust appliances and wood panel-lined basements are...
Biotech Cuts Commercial Data Warehouse Spend 75%
The Challenge After a successful Snowflake proof of concept (POC), our client – a mid-size Commercial Biopharmaceutical company – wanted to migrate its legacy data infrastructure to a modern data stack and bring their Commercial Data Warehouse (CDW) in-house ahead of...
Pharma PAP Improved Patient Time-to-Access by 50%
Ardelyx was founded in 2007 with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Today, Ardelyx (ARDX) is a publicly traded company whose first approved product, IBSRELA® (tenapanor), is...

